Osmotica Pharmaceuticals Plc Overview

Osmotica Pharmaceuticals Plc Cost of Revenue

Cost of Revenue analysis for OSMT.

Quarterly Cost of Revenue

$1.95M

↓ 12.62% YoY

As of Jun 30, 2023

Annual Cost of Revenue (TTM)

$9.33M

↑ 41.34% YoY

Trailing 12 months ending Jun 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin